House Science, Space, and Technology Committee Discusses Research Relief Legislation

  • Oct 2020

On September 9, the House Science, Space, and Technology Committee conducted a hearing about “The Impact of the COVID-19 Crisis on University Research.” While delivering their opening remarks, Haley Stevens (D-MI), chairwoman of the Subcommittee on Research and Technology, and Eddie Bernice Johnson (D-TX), chairwoman of the full Committee, spoke about the financial pressures facing researchers and institutions as they begin to emerge from lockdowns and address other disruptions due to the COVID-19 pandemic. Witnesses at the hearing, including Ryan Muzzio, a graduate student at Carnegie Mellon University, described challenges and delays that they and their colleagues are facing, including the disproportionate impact that women and underrepresented minority scientists experience during the crisis.

The Endocrine Society joined with other scientific societies before and during the hearing on social media to draw attention to and express support for the Research Investment to Spark the Economy (RISE) Act. The RISE Act would authorize approximately $26 billion in emergency relief for federal science agencies, including the NIH, NSF, and others, to allow researchers to safely continue working on federally funded research during this challenging time.

We welcome the Science, Space, and Technology Committee’s efforts to advance the RISE Act and we will continue to advocate for necessary research relief so that we can continue to support researchers during this challenging time and not lose progress on critical endocrine research priorities due to the COVID-19 pandemic.

You may also like

  • Family Matters: Early-Career Scientist Zari McCullers Follows in Her Parents’ Footsteps to the Bench!

    By Glenda Fauntleroy Shaw

    With both her parents working as scientists in the United States Army, it was only natural for Zari McCullers to go into the “family business” when she got the chance. She discusses her career path, how she became focused on the science of addiction, and how making music keeps her grounded when she’s not making…

  • Advocacy in Action – November 2025

    Prescription Drug Pricing Update: Society Continues Advocacy to Lower Price and Out-of-Pocket Costs of Medications    Last month, the Trump Administration and a major retailer took steps to address high prescription drug prices. On September 30, the Trump Administration announced the creation of “TrumpRx,” a consumer website where Americans can buy medications at a discounted price….

Find more in